Skip to main content
. 2015 Mar 20;123(8):773–778. doi: 10.1289/ehp.1408553

Table 1.

Demographic and clinical characteristics and CIMT in the CCA of participants.

Variable Male (n = 497) Female (n = 192) p-Value
Age (years) 49 ± 8 52 ± 8 < 0.001
BMI (kg/m2) 25.6 ± 3.0 23.6 ± 4.0 < 0.001
Systolic blood pressure (mmHg) 125.0 ± 13.9 124.0 ± 15.7 0.42
Diastolic blood pressure (mmHg) 77.6 ± 9.6 76.4 ± 10.3 0.16
Hypertension, yes 147 (29.58) 58 (30.21) 0.86
Cholesterol (mmol/L) 6.0 ± 1.5 6.6 ± 2.0 < 0.001
Triglycerides (mmol/L) 2.7 ± 3.1 2.7 ± 3.4 0.79
Hypercholesterolemiaa, yes 203 (40.8) 99 (51.6) 0.01
HDL-C (mmol/L) 1.3 ± 0.4 1.6 ± 0.5 < 0.001
LDL-C (mmol/L) 3.6 ± 1.3 3.7 ± 1.7 0.63
Fasting blood glucose (mmol/L) 5.5 ± 1.4 5.3 ± 1.1 0.10
DMb, yes 169 (34.0) 68 (35.2) 0.71
Ever smoking habit, yes 163 (32.8) 3 (1.6) < 0.001
Current smoker 108 (21.69) 2 (1.04) < 0.001
Education, < 12 years 106 (21.33) 60 (31.3) 0.006
Lipid-lowering treatment 51 (10.26) 13 (6.77) 0.16
CIMT (mm)
CCA, mean 0.58 ± 0.11 0.56 ± 0.10 0.04
Maximum 0.73 ± 0.14 0.70 ± 0.12 0.06
LCCA, mean 0.59 ± 0.13 0.57 ± 0.12 0.09
Maximum 0.73 ± 0.15 0.72 ± 0.17 0.30
RCCA, mean 0.58 ± 0.12 0.56 ± 0.10 0.04
Maximum 0.72 ± 0.15 0.69 ± 0.11 0.02
Values are mean ± SD or n (%). aCholesterol level ≥ 6.2 mmol/L or being treated with lipid-lowering medications. bFasting glucose levels ≥ 7.0 mmol/L, a history of DM controlled by medication, or DM diagnosed by the oral glucose tolerance test (glucose level at 120 min postchallenge ≥ 11.1 mmol/L).